Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
233
days
Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil
Authors
Radhika Sain; Yann Le Page; Frédéric Percevault; Emmanuelle Becker; Luc Negroni; Almudena Fernandez; Marta Cantero; Diego Muñoz‐Santos; Lluís Montoliu; Cyrille Garnier; Michael PrimigShow moreShow less
Affiliations
1. Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) ‐ UMR_S 1085 Univ Rennes Rennes France; 2. ESBS, ‐BCS‐UMR7242 Illkirch France; 3. National Centre of Biotechnology (CNB‐CSIC) Madrid Spain; 4. Biomedical Research Networking Center on Rare Diseases (CIBERER‐ISCIII) Madrid Spain; 5. Department of Medicine. Faculty of Medicine, Health and Sports Universidad Europea de Madrid Madrid SpainShow moreShow less
132
days
DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients
Authors
Chao Chen; Jiancheng Cheng; Ruili Hou; Xiaoyuan Zheng; Li Su; Maria Moksnes Bjaanæs; Anna Karlsson; Maria Planck; Johan Staaf; Åslaug Helland; Manel Esteller; David C. Christiani; Feng Chen; Xiaofei Cao; Ruyang ZhangShow moreShow less
Affiliations
1. Department of Biostatistics, Center for Global Health, School of Public Health Nanjing Medical University Jiangsu China; 2. Information Center, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University Jiangsu China; 3. Department of Environmental Health Harvard T.H. Chan School of Public Health Boston MA USA; 4. Department of Cancer Genetics Institute for Cancer Research, Oslo University Hospital Norway; 5. Division of Oncology, Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research Lund University Sweden; 6. Institute of Clinical Medicine University of Oslo Norway; 7. Cancer Epigenetics Group Josep Carreras Leukaemia Research Institute (IJC) Barcelona Spain; 8. Centro de Investigación Biomédica en Red Cancer (CIBERONC) Madrid Spain; 9. Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain; 10. Physiological Sciences Department, School of Medicine and Health Sciences University of Barcelona Spain; 11. Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School Boston USA; 12. China International Cooperation Center for Environment and Human Health Nanjing Medical University Jiangsu China; 13. Department of Anesthesiology and Perioperative Medicine, The First School of Clinical Medicine The First Affiliated Hospital of Nanjing Medical University Jiangsu China; 14. Changzhou Medical Center Nanjing Medical University Changzhou Jiangsu China; 15. Laboratory for Digital Intelligence & Health Governance Nanjing Medical University Jiangsu ChinaShow moreShow less
121
days
EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas
Authors
Donovan Pineau; Leonor Garcia; Hugo Arnold; Antonija Hanžek; Maialen Arrieta; Laurent R Gauthier; Christine Granotier‐Beckers; François D Boussin; Amaury Herbet; Marie Hautière; Valentin Asei‐Ceschino; Clémentin Jacques; Laura Brard; Thomas Harnois; Valérie Coronas; Bruno Constantin; Aurélien Chatelier; Jean Chemin; Serge Urbach; Martial Seveno; Szimonetta Hideg; Chantal Ripoll; Kasandra Aguilar‐Cázarez; Min Zheng; Guo‐Hao Huang; Sheng‐Qing Lv; Lei Zhang; Philippe Rondard; Laurent Prezeau; Jean‐Philippe Pin; Hugues Duffau; Luc Bauchet; Valérie Rigau; Franck Denat; Charles Truillet; Didier Boquet; Jean‐Philippe HugnotShow moreShow less
Affiliations
1. Institut de Génomique Fonctionnelle Université de Montpellier, CNRS, INSERM France; 2. University of Bordeaux, CNRS, IBGC UMR5095 France; 3. Université Paris Cité and Université Paris‐Saclay, Inserm, CEA, Stabilité Génétique Cellules Souches et Radiations Fontenay‐aux‐Roses France; 4. Université Paris‐Saclay, CEA, DMTS, SPI France; 5. Institut Génétique Humaine Université de Montpellier, CNRS, INSERM France; 6. 4CS, Laboratory Channels and Connexins in Cancers and Cell Stemness, UR 22751 University of Poitiers France; 7. PReTI Laboratory, UR 24184 University of Poitiers France; 8. BioCampus Montpellier Université de Montpellier, CNRS, INSERM France; 9. Jinfeng Laboratory Chongqing China; 10. Neurosurgery Department Montpellier University Medical Center France; 11. Pathology Department Montpellier University Medical Center France; 12. Université Bourgogne, Europe, CNRS, UMR 6302 Dijon France; 13. Université Paris‐Saclay, CEA, CNRS, Inserm, BioMaps, Orsay FranceShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days